Trust gains indirect voting rights through six entities
Key highlights
- Trust disclosed an indirect voting-rights acquisition dated November 17, 2026 through six holding entities.
- Trust’s largest reported holding-entity interest was 78.07% in Pallawi Trading & Mfg Co Ltd.
- Hindustan Composites’ equity capital remained 1,47,69,000 shares of Rs 5 each before and after the transaction.
- The transaction cited SEBI exemption order WTM/KCV/CFD/09/2026-27 dated July 30, 2026.
powered by IRIS

Shashi Mody Family Trust gained the power to direct voting rights in Hindustan Composites Limited on November 17, 2026 through six holding entities, following an off-market contribution from Mrs. Shashi Mody. The disclosure reports a largest acquired holding-entity interest of 78.07% and unchanged capital of 1,47,69,000 equity shares.
Know Hindustan Composites inside out
Results, valuation, peers and who's buying, in one view.
What did Trust acquire in Hindustan Composites?
Trust acquired shares or interests in six holding entities and consequently gained the power to direct the exercise of voting rights held by those entities in Hindustan Composites. Its November 18, 2026 disclosure classifies the transaction as an indirect acquisition of voting rights rather than a direct acquisition of the listed company’s equity shares.
Before the November 17, 2026 transaction, Trust reported nil shares carrying voting rights in Hindustan Composites. After the acquisition, the Regulation 29(1) disclosure still describes the position as indirect voting rights under Annexure A and does not state one aggregate number of Hindustan Composites shares or voting-rights percentage attributable to Trust.
Trust and Mrs. Shashi Mody are identified as part of Hindustan Composites’ promoter and promoter group in the November 18 filing. The disclosed mechanism was a contribution from Mrs. Shashi Mody, so the filing presents the change as a promoter-group restructuring through holding entities rather than a purchase from a named public shareholder.
Which six entities gave Trust indirect voting rights?
The six entities were Leaders Healthcare Pvt Ltd, Pallawi Trading & Mfg Co Ltd, Pallawi Resources Pvt Ltd, Axon Trading & Mfg Co Ltd, Lotus Udyog LLP and 38 Alipore Consultants LLP. Annexure A records acquired interests ranging from 0.05% in Pallawi Resources Pvt Ltd to 78.07% in Pallawi Trading & Mfg Co Ltd.
The largest percentage interests were 78.07% in Pallawi Trading & Mfg Co Ltd, 50.10% in Leaders Healthcare Pvt Ltd and 43.33% in 38 Alipore Consultants LLP. The smaller reported interests were 26.02% in Axon Trading & Mfg Co Ltd, 0.12% in Lotus Udyog LLP and 0.05% in Pallawi Resources Pvt Ltd.
Annexure A uses share numbers for four entities, including 4,96,000 shares in Leaders Healthcare Pvt Ltd and 65,050 shares in Axon Trading & Mfg Co Ltd, while it describes the LLP interests as capital balances. It does not disclose the number of Hindustan Composites shares held by any of the six entities, preventing a calculation of Trust’s combined indirect voting-rights percentage in the listed company.
How did Trust acquire the voting rights?
Trust acquired the indirect voting rights off market through a contribution received from Mrs. Shashi Mody, according to the November 18, 2026 disclosure. The filing cites Securities and Exchange Board of India, or SEBI, exemption order WTM/KCV/CFD/09/2026-27, dated July 30, 2026, under Regulation 11 of the takeover regulations.
The disclosed acquisition date was November 17, 2026, one day before Trust’s letter was addressed to BSE Limited and copied to SEBI and the National Stock Exchange of India Limited. The filing does not describe an open-market purchase, public issue, rights issue or preferential allotment by Hindustan Composites; it identifies an off-market, indirect transfer through the six entities.
The Regulation 29(1) format lists voting rights acquired otherwise than by equity shares, warrants, convertible securities and other instruments as not applicable. It also records no pledge, lien, non-disposal undertaking or other encumbrance, leaving the reported transaction limited to the contributed interests and resulting voting-rights direction.
Got a follow-up? Ask IRIS
Did Hindustan Composites’ share capital change?
Hindustan Composites’ equity share capital and total voting capital were unchanged at 1,47,69,000 equity shares of Rs 5 each before and after the November 17, 2026 acquisition. The filing also reports total diluted share and voting capital after the transaction at 1,47,69,000 equity shares of Rs 5 each.
The unchanged 1,47,69,000-share figure shows that the reported event did not involve an issue of new Hindustan Composites shares. Instead, the stated change was in Trust’s ownership interests in the six holding entities and its resulting power to direct their voting rights in the company.
The filing does not disclose a price, cash consideration or valuation for the contributed shares and LLP capital balances. Hindustan Composites remains identified as listed on BSE Limited under scrip code 509635 and on the National Stock Exchange of India Limited under symbol HINDCOMPOS.
What does the filing leave undisclosed about Trust’s position?
The filing does not state the number of Hindustan Composites shares owned by each of the six holding entities or the aggregate percentage of voting capital over which Trust can direct votes. The reported 0.05% to 78.07% interests are percentages in the holding entities, not stated percentage holdings in Hindustan Composites.
Trust also does not report receiving direct Hindustan Composites equity shares on November 17, 2026. The filing records nil shares carrying voting rights before the transaction and describes the post-acquisition position only as indirect voting rights, with no warrants, convertibles or other equity-linked instruments disclosed.
The disclosure therefore provides the ownership structure of the six transferred interests but not the listed-company voting-rights total represented by those interests. That distinction matters because the 1,47,69,000 equity shares outstanding did not change, while the direction of votes held through the entities did.
Conclusion
The November 17, 2026 restructuring gave Trust indirect voting-rights direction through six promoter-group holding entities without changing Hindustan Composites’ 1,47,69,000 equity shares. The largest reported acquired interest was 78.07% in Pallawi Trading & Mfg Co Ltd, followed by 50.10% in Leaders Healthcare Pvt Ltd.
The next disclosure to watch is any promoter-shareholding update that quantifies the Hindustan Composites shares and voting-rights percentage represented by Trust’s new indirect position. The November 18 filing identifies the July 30, 2026 SEBI exemption order and the six entity interests, but leaves that aggregate voting-rights figure unresolved.


